MSH|^~\&|LAB|Dynacare|||20240604121417-0400||ORU^R01|21247402|D|2.3|||||||enCA
PID|1||2222225941^^^^JHN^~^^^^XXOEI^||ITTESTING^STG5941CD^ORDER#2||19601120|M|||4215 STONEMASON CRES^^MISSISSAUGA^ON^L5L2Z6^||^|||||
ORC||^Dynacare|5010021689||CM||||20240604085008-0400||||||||^ONLY^DYNA
OBR|1|^Dynacare|5010021689|ENAD^ENA AB SCREENING^DYNA|||20240604085000-0400|||||||20240604085008-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA||||IMMUN|401100|20240604120943-0400|||F|^^||^GUESS^GUESS
OBX|1|TX|ENAD^ENA AB SCREENING^DYNA|401100|NEGATIVE||NEGATIVE|N|||F|||20240604120943-0400
NTE|1|RS||RS^^DYNA^IM23
NTE|2|RS|This specimen has been screened for SS-A (Ro),|RS^^DYNA^IM23
NTE|3|RS|SS-B (La), Sm (Smith), RNP, Scl-70 and Jo-1.|RS^^DYNA^IM23
NTE|4|RS||RS^^DYNA^IM23
NTE|5|RF|NEGATIVE|RF^^^
OBR|2|^Dynacare|5010021689|TAY^TAY SACHS^DYNA|||20240604085000-0400|||||||20240604085008-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA||||REFER|901515|20240604121024-0400|||F|^^||^GUESS^GUESS
OBX|1|TX|TAY^TAY SACHS^DYNA|901515|See Notes|||I|||F|||20240604121024-0400
NTE|1|RS||RS^^DYNA^RF06
NTE|2|RS|Test Performed at: The Hospital For Sick Children|RS^^DYNA^RF06
NTE|3|RS|555 University Ave, Toronto, ON MG5 1X8|RS^^DYNA^RF06
NTE|4|RS||RS^^DYNA^RF06
OBX|2|TX|TAY^TAY SACHS^DYNA|901515|\.br\           The report will be sent directly to the client by the                  \.br\           testing lab.                                                           \.br\|||I|||F|||20240604121024-0400
OBR|3|^Dynacare|5010021689|078R^DRUGS OF ABUSE RDM URINE^DYNA|||20240604085000-0400|||||||20240604085008-0400|^^^^|699999^ONLY^TEST^^^^^^DYNA||||TOXIC|806420|20240604121020-0400|||F|^^||^GUESS^GUESS
OBX|1|TX|078R^DRUGS OF ABUSE RDM URINE^DYNA|806420|POSITIVE|||I|||F|||20240604121020-0400
NTE|1|RS||RS^^DYNA^IGCT
NTE|2|RS|Immunoassay-based urine drug screens only provide|RS^^DYNA^IGCT
NTE|3|RS|presumptive analytical test results.  Clinical|RS^^DYNA^IGCT
NTE|4|RS|consideration and professional judgment should be|RS^^DYNA^IGCT
NTE|5|RS|applied.|RS^^DYNA^IGCT
NTE|6|RS||RS^^DYNA^IGCT
NTE|7|RS|For further information, please consult the Interpretation|RS^^DYNA^IGCT
NTE|8|RS|Guide: Immunoassay-based Urine Drug Screening on the|RS^^DYNA^IGCT
NTE|9|RS|Dynacare website at the following link:|RS^^DYNA^IGCT
NTE|10|RS|https://www.dynacare.ca/news-room/notices/services/|RS^^DYNA^IGCT
NTE|11|RS|immunoassay-based-urine-drug-screening.aspx|RS^^DYNA^IGCT
OBX|2|TX|AMPHE^AMPHETAMINE^DYNA|806420.001|negative|ng/mL||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF  1000 ng/mL|RF^^^
OBX|3|TX|BARBIT^BARBITURATES^DYNA|806420.002|negative|ng/mL||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF   300 ng/mL|RF^^^
OBX|4|TX|BENZOD^BENZODIAZEPINES^DYNA|806420.003|negative|ng/mL||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF   300 ng/mL|RF^^^
OBX|5|TX|CANN^CANNABINOIDS(THCA)^DYNA|806420.004|negative|ng/mL||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF    50 ng/mL|RF^^^
OBX|6|TX|COCAME^COCAINE METABOLITE^DYNA|806420.005|negative|ng/mL||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF   300 ng/mL|RF^^^
OBX|7|TX|ETHANO^ETHANOL^DYNA|806420.006|negative|mmol/L||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF    4 mmol/L|RF^^^
OBX|8|TX|MET^METHADONE^DYNA|806420.007|POS 135|ng/mL||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF   300 ng/mL|RF^^^
OBX|9|TX|OPIAT^OPIATES^DYNA|806420.008|negative|ng/mL||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF   300 ng/mL|RF^^^
OBX|10|TX|METHME^METHADONE METABOLITE^DYNA|806420.009|POS 516|ng/mL||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF   100 ng/mL|RF^^^
OBX|11|TX|OXYCO^OXYCODONE^DYNA|806420.010|negative|ng/mL||I|||F|||20240604121020-0400
NTE|1|RF|CUT-OFF   100 ng/mL|RF^^^
